Alkem Laboratories Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1973

Chairman: Basudeo N Singh

Managing Director: Sandeep Singh

Group: --

Listing: NSE: ALKEM, BSE: 539523

Headquarters: Mumbai, Maharashtra

Website: www.alkemlabs.com

Key Facts

Market cap: R 27,858.65 Cr

Revenue (TTM): R 7,892.76 Cr

Earnings (TTM): R 943.76 Cr

Cash: R 889.48 Cr

Total Debt: R 944.07 Cr

Promoters' ownership: 66.04%

Liquidity: High

52 Week range: R 1,660.00 - 2,405.00

Face value: R2.00

Shares outstanding: 11,95,65,000

Stock Performance

Trailing
Annual

Time Period	Alkem Laboratories	S&P BSE Mid Cap	S&P BSE Healthcare
YTD	15.68	4.90	5.04
1 month	16.29	5.93	5.36
3 months	18.45	9.07	9.68
1 Year	24.02	5.50	0.28
3 Years	12.34	7.48	-1.51
5 Years	--	7.98	-1.88
10 Years	--	8.75	11.24

As on 23-Jan-2020

Year	Alkem Laboratories	S&P BSE Mid Cap	S&P BSE Healthcare
2019	3.79	-3.05	-3.55
2018	-11.42	-13.31	-5.89
2017	35.20	48.13	0.49
2016	8.35	7.97	-12.88

Annual Report (FY18)

Review & Analysis

How did MFs fare as anchor investors?
Kumar Shankar Roy . 27-Apr-2016

News & Announcements

Shareholding for the Period Ended December 31 2019
08-Jan-2020
Statement Of Investor Complaints For The Quarter Ended December 2019
06-Jan-2020
Announcement under Regulation 30 (LODR)-Acquisition
31-Dec-2019
Closure of Trading Window
23-Dec-2019
Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-Nov-2019